Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD): a Randomized Clinical Trial and Cost-utility Analysis

NCT05321680 is registered in ClinicalTrials.gov with Centro Hospitalar De São João, E.P.E. as lead sponsor.

NCT NCT05321680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD): a Randomized Clinical Trial and Cost-utility Analysis
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
March 20, 2022
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia